APPLICATION
ANDA204041
TYPE
ANDA
ORIGINAL APPROVAL
2016-05-20
LATEST ACTION
2019-12-03
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
ZOLMITRIPTANPrescription
ZOLMITRIPTAN 2.5MG · TABLET · ORAL
ZOLMITRIPTANPrescription
ZOLMITRIPTAN 5MG · TABLET · ORAL
Approval history
2019-12-03Labeling · Supplement 3 · standardAP
2016-05-20UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.